International Business

No restriction on export of iron ore, says Minister

The government today said there would be no restriction on export of iron ore, as there is surplus of the mineral in the country even after its export. - Commerce Ministry wants Finmin to take up exporters" issue - Infosys wins 10-year contract from govt - FY10 Exim policy may have steps to stem exports slowdown - Measures being taken to check anti-dumping activity: Govt - Announce ad hoc Foreign Trade Policy - Sreelatha Menon: The Blue Room">Sreelatha Menon: The Blue Room Minister for Commerce and Industry Anand Sharma today informed Rajya Sabha during Question Hour that "there have been demands from time to time for restricting the export of major minerals like iron ore, manganese ore and chrome ore". While there are quantitative and qualitative restrictions on export of Manganese and Chrome Ore, in case of iron ore, iron ore lumps and fines of iron content, more than 64 per cent are canalised for export, he said. "There are quantitative restrictions in respect of export of high grade Bailadila iron ore. In respect of iron ore lumps and fines of less than 64 per cent iron content, there are no restrictions on export. However iron ore lumps attract a five per cent advalorem export duty," he added.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
7-8% yield not dangerous: Chakrabarty
Current market fluctuations in bonds yields were not dangerous, and a 10-year yield of 7-8 per cent was not uncomfortable, Reserve Bank of India (RBI) Deputy Governor K C Chakrabarty said today.
Popular Articles
quick payday loans

Kotak bets big on M&A deals, ties up with Russian bank
Betting big on the growing India-related M&A deals, private-sector lender Kotak Mahindra Bank today entered into a pact with Russian investment bank, Renaissance capital, to advise cross-border transactions.

Wockhardt, Sun get US okay for generic drug
Indian drug companies Wockhardt and Sun Pharmaceutical Industries have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.